<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-37391" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Exudative Retinitis (Coats Disease)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Abhishek</given-names>
          </name>
          <aff>IGIMS</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Paulbuddhe</surname>
            <given-names>Vivek S.</given-names>
          </name>
          <aff>ASG Eye hospital, Guwahati, Assam, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shukla</surname>
            <given-names>Unnati V.</given-names>
          </name>
          <aff>Centre for Sight new delhi</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abhishek Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vivek Paulbuddhe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Unnati Shukla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-37391.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Coats disease is an idiopathic ocular condition characterized by retinal telangiectasia and exudation. The incidence is relatively low, hence recognizing it will help in the early diagnosis and treatment. This activity reviews the evaluation and management of Coats disease and explains the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of Coats disease.</p></list-item><list-item><p>Explain the typical presentation of a patient with Coats disease.</p></list-item><list-item><p>Review the typical imaging findings associated with Coats disease.</p></list-item><list-item><p>Summarize the importance of collaboration and communication amongst the interprofessional team to improve outcomes for patients affected by Coats disease.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37391&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37391">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-37391.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Coats disease is an idiopathic ocular condition characterized by retinal telangiectasia, aneurysms, and exudation.<xref ref-type="bibr" rid="article-37391.r1">[1]</xref><xref ref-type="bibr" rid="article-37391.r2">[2]</xref><xref ref-type="bibr" rid="article-37391.r3">[3]</xref>&#x000a0;George Coats first described it in 1908 as a unilateral condition with retinal exudation and telangiectasia in male children.<xref ref-type="bibr" rid="article-37391.r4">[4]</xref> Later, Theodor von Leber described a similar&#x000a0;case with telangiectatic and aneurysmal vessels without subretinal exudation.<xref ref-type="bibr" rid="article-37391.r2">[2]</xref>&#x000a0;This condition was later known as Leber multiple miliary aneurysms.<xref ref-type="bibr" rid="article-37391.r2">[2]</xref>&#x000a0;It was identified as an earlier disease process of Coats disease.&#x000a0;Subsequently, Shields et al. defined Coats disease as&#x000a0;<italic toggle="yes">&#x02018;</italic>idiopathic retinal telangiectasia associated with exudation and frequent exudative retinal detachment with no signs of retinal or vitreal traction.&#x02019;<xref ref-type="bibr" rid="article-37391.r5">[5]</xref></p>
      </sec>
      <sec id="article-37391.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Coats disease is usually sporadic.<xref ref-type="bibr" rid="article-37391.r4">[4]</xref> Considering the unilateral and sporadic nature of the disease, a somatic mutation is more likely.<xref ref-type="bibr" rid="article-37391.r6">[6]</xref>&#x000a0;Coats disease is characterized by peripheral retinal avascularity similar to other diseases like&#x000a0;Norrie disease, familial exudative vitreoretinopathy (FEVR), facioscapulohumeral muscular dystrophy (FSHD), and osteoporosis pseudoglioma syndrome.<xref ref-type="bibr" rid="article-37391.r7">[7]</xref><xref ref-type="bibr" rid="article-37391.r8">[8]</xref><xref ref-type="bibr" rid="article-37391.r9">[9]</xref><xref ref-type="bibr" rid="article-37391.r10">[10]</xref><xref ref-type="bibr" rid="article-37391.r11">[11]</xref><xref ref-type="bibr" rid="article-37391.r12">[12]</xref><xref ref-type="bibr" rid="article-37391.r13">[13]</xref>&#x000a0;All of these conditions are related to abnormalities in the Wnt signaling pathway during retinal angiogenesis.<xref ref-type="bibr" rid="article-37391.r7">[7]</xref><xref ref-type="bibr" rid="article-37391.r8">[8]</xref>&#x000a0;</p>
        <p>Cremers and colleagues found a mutation in the CRB1 gene in 55% of eyes with retinitis pigmentosa and Coats-like secondary exudative vasculopathy.<xref ref-type="bibr" rid="article-37391.r14">[14]</xref>&#x000a0;They suggested that CRB1 could be involved in primary Coats disease as well as other retinal conditions.<xref ref-type="bibr" rid="article-37391.r14">[14]</xref> Several reports have&#x000a0;suggested a missense mutation within the Norrie disease pseudoglioma gene, NDP, on chromosome Xp11.2 in the pathogenesis of Coats disease.<xref ref-type="bibr" rid="article-37391.r15">[15]</xref><xref ref-type="bibr" rid="article-37391.r16">[16]</xref><xref ref-type="bibr" rid="article-37391.r17">[17]</xref><xref ref-type="bibr" rid="article-37391.r18">[18]</xref><xref ref-type="bibr" rid="article-37391.r19">[19]</xref>&#x000a0;Mutation in the PANK2 gene has also been implicated in Coats disease.<xref ref-type="bibr" rid="article-37391.r6">[6]</xref><xref ref-type="bibr" rid="article-37391.r20">[20]</xref><xref ref-type="bibr" rid="article-37391.r6">[6]</xref></p>
      </sec>
      <sec id="article-37391.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Morris et al. conducted a population bases study of&#x000a0;Coats disease.<xref ref-type="bibr" rid="article-37391.r21">[21]</xref>&#x000a0;The incidence&#x000a0;was 0.09 per 100,000 population. All cases were unilateral, and 85% were male.<xref ref-type="bibr" rid="article-37391.r21">[21]</xref>&#x000a0;The mean age at presentation was 146 months (median 96 months).&#x000a0;Some authors have reported that the disease could be present at birth.<xref ref-type="bibr" rid="article-37391.r22">[22]</xref>&#x000a0;In a large series, only 5% of cases were bilateral.<xref ref-type="bibr" rid="article-37391.r2">[2]</xref>&#x000a0;The&#x000a0;fellow&#x000a0;eye was usually without symptoms and had subtle peripheral telangiectatic changes.<xref ref-type="bibr" rid="article-37391.r2">[2]</xref>&#x000a0;Adult-onset Coats disease (first diagnosed at a minimum age of 35 years)&#x000a0;constituted 7% of the 646 patients with Coats disease in a tertiary eye care center.<xref ref-type="bibr" rid="article-37391.r23">[23]</xref>&#x000a0;The mean age at diagnosis of adult-onset Coats disease was 47 years in this series.<xref ref-type="bibr" rid="article-37391.r23">[23]</xref></p>
      </sec>
      <sec id="article-37391.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In Coats disease, the blood-retinal barrier breaks down, which causes plasma leakage into the vessel wall.<xref ref-type="bibr" rid="article-37391.r24">[24]</xref> The blood vessels become thickened and necrosed.<xref ref-type="bibr" rid="article-37391.r24">[24]</xref>&#x000a0;This leads to a &#x02018;sausage-like&#x02019; shape of the vessel. The abnormal pericytes and endothelial cells in retinal blood vessels subsequently degenerate. These blood vessels form aneurysms and later occlude,&#x000a0;leading to ischemia and rarely neovascularization.<xref ref-type="bibr" rid="article-37391.r25">[25]</xref></p>
      </sec>
      <sec id="article-37391.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Coats&#x000a0;studied the&#x000a0;histologic features of enucleated eyes.<xref ref-type="bibr" rid="article-37391.r6">[6]</xref> He described the subretinal fibrous tissue masses as tightly adherent to the outer retina. Most of the eyes had associated retinal thickening, degeneration, detachment, hemorrhages, cholesterol crystals, and vascular abnormalities.<xref ref-type="bibr" rid="article-37391.r6">[6]</xref> One eye had evidence of bone formation. Other authors have also described the histopathologic features such as&#x000a0;bullous retinal detachment and the presence of subretinal fluid. The outer retina is thickened&#x000a0;due to exudation, and the inner retina contains telangiectatic vessels. The retinal vessels&#x000a0;have&#x000a0;perivascular sheathing and are&#x000a0;degenerated. There is capillary dropout with areas of&#x000a0;neovascularization.<xref ref-type="bibr" rid="article-37391.r26">[26]</xref><xref ref-type="bibr" rid="article-37391.r27">[27]</xref><xref ref-type="bibr" rid="article-37391.r28">[28]</xref><xref ref-type="bibr" rid="article-37391.r29">[29]</xref><xref ref-type="bibr" rid="article-37391.r30">[30]</xref>&#x000a0;Thick PAS (Periodic acid&#x02013;Schiff)-positive deposits in the&#x000a0;wall of retinal vessels and large aneurysms are typically seen in Coats disease.<xref ref-type="bibr" rid="article-37391.r24">[24]</xref> Kase et al. have reported&#x000a0;increased vascular endothelial growth factor (VEGF) levels in eyes with vascular abnormalities. They noted&#x000a0;VEGF immunoreactivity in retinal macrophages and endothelium of blood vessels.<xref ref-type="bibr" rid="article-37391.r31">[31]</xref></p>
      </sec>
      <sec id="article-37391.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The presenting symptoms are varied. The patients can present with decreased visual acuity (43%), strabismus (23%), leukocoria/xanthocoria (20%), pain (3%), heterochromia (1%), and nystagmus (1%).<xref ref-type="bibr" rid="article-37391.r2">[2]</xref>&#x000a0;Eight percent of patients may be asymptomatic and are detected coincidentally on routine examination.<xref ref-type="bibr" rid="article-37391.r2">[2]</xref>&#x000a0;</p>
        <p>Visual acuity can range from 20/20 to 20/50 in 12% of cases, 20/60 to 20/100 in 11%, 20/200 to counting fingers in 18%, and hand motions to no light perception in 58%.<xref ref-type="bibr" rid="article-37391.r2">[2]</xref>&#x000a0;The main causes of poor vision include subfoveal fluid or lipids, subfoveal fibrosis, macular edema, epiretinal membrane, and optic atrophy.<xref ref-type="bibr" rid="article-37391.r5">[5]</xref>&#x000a0;The anterior segment is normal in 90% of cases. Those with findings include cataract, iris neovascularization, shallow anterior chamber, corneal edema due to high intraocular pressure, cholesterol in the anterior chamber, and megalocornea.<xref ref-type="bibr" rid="article-37391.r32">[32]</xref><xref ref-type="bibr" rid="article-37391.r33">[33]</xref>&#x000a0;</p>
        <p>Retinal findings include telangiectasia, fusiform aneurysms, and intraretinal exudation. There may be&#x000a0;sheathing of the vasculature.<xref ref-type="bibr" rid="article-37391.r5">[5]</xref>&#x000a0;These findings are generally noted in the inferotemporal quadrant in the peripheral zones between the equator to ora serrata.<xref ref-type="bibr" rid="article-37391.r5">[5]</xref>&#x000a0;As the disease progresses, fluid exudation leads to&#x000a0;exudative retinal detachment, retinal hemorrhage,&#x000a0;vasoproliferative tumor, macular fibrosis, and&#x000a0;optic disc neovascularization.<xref ref-type="bibr" rid="article-37391.r34">[34]</xref>&#x000a0;Advanced&#x000a0;complications such as iridocyclitis, cataract, and secondary neovascular glaucoma can lead to phthisis bulbi.<xref ref-type="bibr" rid="article-37391.r35">[35]</xref><xref ref-type="bibr" rid="article-37391.r36">[36]</xref><xref ref-type="bibr" rid="article-37391.r37">[37]</xref>&#x000a0;</p>
        <p>Adult-onset Coats disease is characterized by systemic associations (usually hypertension), incidental detection, involvement of less than six clock hours of the retina, a benign natural course of the disease, and usually better visual outcomes compared to childhood-onset Coats disease.<xref ref-type="bibr" rid="article-37391.r23">[23]</xref>&#x000a0;Seventy-three percent of patients with the adult-onset disease were male, and 93% of cases had unilateral involvement.<xref ref-type="bibr" rid="article-37391.r23">[23]</xref></p>
      </sec>
      <sec id="article-37391.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of Coats disease is clinical. Ancillary investigations are done when the diagnosis is in doubt, particularly with&#x000a0;bullous retinal detachment with exudation and dilated vessels.</p>
        <p>
<bold>Fundus Fluorescein Angiography (FFA)</bold>
</p>
        <p>The typical fluorescein angiographic features are telangiectasia, aneurysms, beading of vessel walls, and peripheral retinal nonperfusion.<xref ref-type="bibr" rid="article-37391.r38">[38]</xref> The anomalous vessels show early leakage, which continues until the late phase.<xref ref-type="bibr" rid="article-37391.r39">[39]</xref>&#x000a0;The aneurysms&#x000a0;are clearly visible as &#x02018;light bulb&#x02019; dilations on the larger blood vessels. In the periphery, areas of capillary drop out and rarely neovascularization can be seen. FFA helps in treatment by identifying the telangiectatic leaking vessels, which can be selectively lasered. It also highlights the areas of nonperfusion which can be treated with photocoagulation in cases of neovascularization or even before the development of neovascularization.<xref ref-type="bibr" rid="article-37391.r5">[5]</xref><xref ref-type="bibr" rid="article-37391.r40">[40]</xref><xref ref-type="bibr" rid="article-37391.r41">[41]</xref>&#x000a0;With the development of wide-field angiography machines such as Retcam and Optos, peripheral vascular anomalies can be detected and selectively laser targeted.<xref ref-type="bibr" rid="article-37391.r42">[42]</xref></p>
        <p>
<bold>Optical Coherence Tomography (OCT)</bold>
</p>
        <p>OCT is helpful in monitoring for macular involvement. It helps in documenting cystoid macular edema, epiretinal membrane, subretinal/intraretinal fluid, subfoveal lipids, central macular thickness, and subfoveal choroidal thickness.<xref ref-type="bibr" rid="article-37391.r43">[43]</xref>&#x000a0;In a study, subretinal compact hyperreflectivity (fibrosis) and outer retinal atrophy were associated with worse final visual acuity.<xref ref-type="bibr" rid="article-37391.r44">[44]</xref></p>
        <p>
<bold>OCT Angiography (OCTA)</bold>
</p>
        <p>OCTA may be used to monitor the disease and response to therapy non-invasively.<xref ref-type="bibr" rid="article-37391.r45">[45]</xref><xref ref-type="bibr" rid="article-37391.r46">[46]</xref>&#x000a0;Reported OCTA feature of Coats disease&#x000a0;after therapy includes chorioretinal anastomoses, abnormal foveal vascular loops, and flow voids in the choroid.<xref ref-type="bibr" rid="article-37391.r45">[45]</xref>&#x000a0;Abnormal foveal avascular zone (FAZ) with retinal vessels traversing the FAZ may be noted in the affected and the fellow eye in cases with unilateral Coats disease.<xref ref-type="bibr" rid="article-37391.r47">[47]</xref></p>
        <p>
<bold>Ocular Ultrasonography (USG)</bold>
</p>
        <p>It depicts the extent of retinal detachment. It characterizes the subretinal space, which is usually acoustically clear, but sometimes hyperechogenicity can be seen due to the presence of cholesterol deposits. Calcification can occur in advanced Coats disease along the retinal pigmentary epithelium. It is seen as a curvilinear pattern in contrast to retinoblastoma, where it is randomly distributed.<xref ref-type="bibr" rid="article-37391.r4">[4]</xref></p>
        <p>The analysis of subretinal fluid sometimes helps in diagnosis by demonstrating lipid-laden macrophages and cholesterol crystals.<xref ref-type="bibr" rid="article-37391.r2">[2]</xref></p>
        <p>
<bold>Computed Tomography (CT)&#x000a0;</bold>
</p>
        <p>CT&#x000a0;is useful to rule out retinoblastoma. The presence of a solid mass with calcification is present in retinoblastoma. This is better delineated in the CT scan. In Coats disease, the scan would be clear of these lesions.<xref ref-type="bibr" rid="article-37391.r48">[48]</xref><xref ref-type="bibr" rid="article-37391.r49">[49]</xref>&#x000a0;CT also&#x000a0;highlights the intraocular morphology and the subretinal exudation.</p>
        <p>
<bold>Magnetic Resonance Imaging (MRI)</bold>
</p>
        <p>MRI&#x000a0;may be useful in diagnosing advanced Coats disease and ruling out retinoblastoma. The exudate in Coats disease is hyperintense on both T1-weighted and T2-weighted MRI images, whereas in retinoblastoma, the T1-weighted image will show a hyperintense mass, but the T2-weighted image shows a hypointense mass.<xref ref-type="bibr" rid="article-37391.r48">[48]</xref><xref ref-type="bibr" rid="article-37391.r50">[50]</xref>&#x000a0;Retinoblastoma&#x000a0;shows enhancement with gadolinium contrast, a feature not seen in Coats disease.<xref ref-type="bibr" rid="article-37391.r1">[1]</xref></p>
      </sec>
      <sec id="article-37391.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment for Coats disease depends on the stage of the disease. Mild cases with only retinal telangiectasia and no exudation can be observed and followed up at regular intervals. Treatment is&#x000a0;needed when&#x000a0;exudation develops. In less severe cases of exudation, laser photocoagulation to telangiectatic vessels is done.<xref ref-type="bibr" rid="article-37391.r51">[51]</xref><xref ref-type="bibr" rid="article-37391.r52">[52]</xref><xref ref-type="bibr" rid="article-37391.r53">[53]</xref>&#x000a0;</p>
        <p>FFA helps in detecting the leaking vessels.<xref ref-type="bibr" rid="article-37391.r42">[42]</xref>&#x000a0;These are directly treated with moderate intensity burns. Laser therapy causes inflammation and leads to a transient increase in exudation. So, multiple sessions of laser are needed at intervals of 2&#x000a0;to 3 months. But the laser is ineffective in cases of extensive subretinal exudation&#x000a0;and retinal detachment.&#x000a0;Cryotherapy is useful in such cases. It is done by a double freeze-thaw technique over the affected retina. Cryotherapy is associated with more inflammation, pain, and sometimes exudative retinal detachment, so&#x000a0;therapy should be limited per session and divided into multiple sessions.</p>
        <p>Advanced cases with&#x000a0;bullous exudative detachment abutting the lens might benefit from surgery. The subretinal fluid is drained either trans-sclerally or internally. The detached retina gets approximated. Pan retinal photocoagulation or cryotherapy is then done. In cases with the rhegmatogenous or tractional&#x000a0;component, pars plana vitrectomy is done with or without tamponade. Surgery primarily aims to prevent a painful blind eye and avoid enucleation rather than vision restoration.</p>
        <p>Enucleation is done in endstage&#x000a0;disease with neovascularization or angle-closure glaucoma.<xref ref-type="bibr" rid="article-37391.r5">[5]</xref><xref ref-type="bibr" rid="article-37391.r54">[54]</xref>&#x000a0;Alternatively,&#x000a0;transscleral diode laser cyclophotocoagulation can be tried in eyes with neovascular glaucoma.<xref ref-type="bibr" rid="article-37391.r55">[55]</xref>&#x000a0;</p>
        <p>Intravitreal corticosteroids and anti-VEGF agents&#x000a0;may effectively reduce macular edema and subretinal fluid.<xref ref-type="bibr" rid="article-37391.r56">[56]</xref><xref ref-type="bibr" rid="article-37391.r57">[57]</xref><xref ref-type="bibr" rid="article-37391.r58">[58]</xref><xref ref-type="bibr" rid="article-37391.r59">[59]</xref><xref ref-type="bibr" rid="article-37391.r60">[60]</xref><xref ref-type="bibr" rid="article-37391.r61">[61]</xref><xref ref-type="bibr" rid="article-37391.r62">[62]</xref><xref ref-type="bibr" rid="article-37391.r63">[63]</xref><xref ref-type="bibr" rid="article-37391.r64">[64]</xref>&#x000a0;They are employed as adjunctive agents. They can also be given before laser and cryotherapy to reduce the reactive exudation associated with them.<xref ref-type="bibr" rid="article-37391.r65">[65]</xref></p>
      </sec>
      <sec id="article-37391.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Diseases that produce leukocoria<xref ref-type="bibr" rid="article-37391.r66">[66]</xref>&#x000a0;and strabismus can simulate Coats disease.<xref ref-type="bibr" rid="article-37391.r66">[66]</xref> The differential diagnosis includes retinoblastoma, FEVR, retinal detachment, Noorie disease, persistent hyperplastic primary vitreous (PHPV), retinopathy of prematurity (ROP), congenital cataract, retinal hemorrhage, hemangioblastoma, toxocariasis,&#x000a0;choroidal hemangioma, coloboma, endophthalmitis,&#x000a0;cytomegalovirus retinitis, and toxoplasmosis.<xref ref-type="bibr" rid="article-37391.r67">[67]</xref><xref ref-type="bibr" rid="article-37391.r68">[68]</xref><xref ref-type="bibr" rid="article-37391.r67">[67]</xref> The most important differential is retinoblastoma.&#x000a0;Retinoblastoma is the most common intraocular malignancy in children and is fatal if left untreated. Coats disease is the most common cause of&#x000a0;erroneous enucleation reported.<xref ref-type="bibr" rid="article-37391.r2">[2]</xref>&#x000a0;</p>
        <p>Retinoblastoma can present in a younger child below one year; Coats disease is not as common in this age group and generally presents after 2&#x000a0;or 3 years. The large vessels in retinoblastoma go subretinally within the tumor, whereas in Coats disease, the telangiectatic vessels are always noted in the retinal surface. Bilaterality is common in&#x000a0;retinoblastoma but very rare in Coats disease.&#x000a0;Retinoblastoma often has a family history, but family history is usually not present in Coats disease. Retinoblastoma presents with leukocoria, and Coats disease has xanthocoria. On USG, retinoblastoma presents as a solid mass and calcification with shadowing. This feature is absent in Coats. The calcification in retinoblastoma is randomly distributed. Calcification in Coats is rare but, if present, is curvilinearly distributed along the retinal pigment epithelium.</p>
        <p>FEVR and Noorie disease can be differentiated based on&#x000a0;bilaterality,&#x000a0;a positive family history, and the presence of retinal dragging, all of which are rare in Coats disease. Retinopathy of prematurity (ROP) is seen in preterm low birth-weight babies. Proliferative retinopathy due to chronic rhegmatogenous retinal detachment and pars planitis is another differential.</p>
        <p>The classical finding in Coats is dilated telangiectatic vessels, aneurysms, hard exudates, peripheral avascularity, and exudative retinal detachment.</p>
        <p>Sometimes a mass forms which might simulate</p>
        <list list-type="bullet">
          <list-item>
            <p>Melanoma,</p>
          </list-item>
          <list-item>
            <p>Papillary or retinal capillary hemangioblastoma,</p>
          </list-item>
          <list-item>
            <p>Choroidal granuloma (sarcoidosis, tuberculosis), and</p>
          </list-item>
          <list-item>
            <p>Vasoproliferative tumor.</p>
          </list-item>
        </list>
        <p>Other differential diagnoses of diseases with extensive hard exudates include</p>
        <list list-type="bullet">
          <list-item>
            <p>Branch retinal venous occlusion,</p>
          </list-item>
          <list-item>
            <p>Vasoproliferative tumor,</p>
          </list-item>
          <list-item>
            <p>Capillary hemangioma,</p>
          </list-item>
          <list-item>
            <p>Chronic retinal detachment,</p>
          </list-item>
          <list-item>
            <p>Trauma, and</p>
          </list-item>
          <list-item>
            <p>Inflammation.</p>
          </list-item>
        </list>
        <p>A Coats-like response (retinal telangiectasia, aneurysm, and hard exudates) may also be noted in</p>
        <list list-type="bullet">
          <list-item>
            <p>Retinitis pigmentosa<xref ref-type="bibr" rid="article-37391.r69">[69]</xref></p>
          </list-item>
          <list-item>
            <p>Healed choroiditis<xref ref-type="bibr" rid="article-37391.r70">[70]</xref></p>
          </list-item>
          <list-item>
            <p>Tubercular subretinal abscess<xref ref-type="bibr" rid="article-37391.r71">[71]</xref></p>
          </list-item>
          <list-item>
            <p>Retinal vasculitis,<xref ref-type="bibr" rid="article-37391.r72">[72]</xref></p>
          </list-item>
          <list-item>
            <p>Pars planitis<xref ref-type="bibr" rid="article-37391.r73">[73]</xref><xref ref-type="bibr" rid="article-37391.r74">[74]</xref><xref ref-type="bibr" rid="article-37391.r75">[75]</xref></p>
          </list-item>
          <list-item>
            <p>Leber Congenital amaurosis<xref ref-type="bibr" rid="article-37391.r76">[76]</xref></p>
          </list-item>
          <list-item>
            <p>Facioscapulohumeral muscular dystrophy and deafness,</p>
          </list-item>
          <list-item>
            <p>Progressive facial hemiatrophy or&#x000a0;Parry-Romberg syndrome or&#x000a0;progressive hemifacial atrophy or&#x000a0;hemifacial atrophy<xref ref-type="bibr" rid="article-37391.r77">[77]</xref></p>
          </list-item>
          <list-item>
            <p>Isolated hemihyperplasia</p>
          </list-item>
          <list-item>
            <p>Tuberous sclerosis</p>
          </list-item>
          <list-item>
            <p>Alport's syndrome</p>
          </list-item>
          <list-item>
            <p>X-linked retinoschisis and regressed retinopathy of prematurity<xref ref-type="bibr" rid="article-37391.r78">[78]</xref></p>
          </list-item>
          <list-item>
            <p>'Blood-filled senile retinoschisis'<xref ref-type="bibr" rid="article-37391.r79">[79]</xref></p>
          </list-item>
          <list-item>
            <p>Linear Scleroderma<xref ref-type="bibr" rid="article-37391.r80">[80]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>En coup de sabre scleroderma<xref ref-type="bibr" rid="article-37391.r81">[81]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Epidermal nevus syndrome</p>
          </list-item>
        </list>
        <p>As described by Gass and Blodi,&#x000a0;type I macular telangiectasia is characterized by nonfamilial and usually unilateral disease with retinal telangiectasia and hard exudates.<xref ref-type="bibr" rid="article-37391.r82">[82]</xref> This disease is thought to lie in the spectrum of Coats disease.<xref ref-type="bibr" rid="article-37391.r83">[83]</xref>&#x000a0;The peripheral retinal yellow hard exudates in retinitis pigmentosa with a Coats-like response may be misdiagnosed as acute retinal necrosis.<xref ref-type="bibr" rid="article-37391.r84">[84]</xref><xref ref-type="bibr" rid="article-37391.r85">[85]</xref>&#x000a0;Coats-like disease in FSHD is seen in around 75% of patients angiographically.<xref ref-type="bibr" rid="article-37391.r86">[86]</xref> The retinal involvement is usually bilateral.<xref ref-type="bibr" rid="article-37391.r86">[86]</xref>&#x000a0;The posterior pole is usually not involved, and the disease&#x000a0;usually has milder severity.<xref ref-type="bibr" rid="article-37391.r86">[86]</xref>&#x000a0;Visual loss is rarely (1%) noted.<xref ref-type="bibr" rid="article-37391.r86">[86]</xref>&#x000a0;Such bilateral Coats-like response in FSHD may&#x000a0;affect females.<xref ref-type="bibr" rid="article-37391.r87">[87]</xref></p>
      </sec>
      <sec id="article-37391.s11" sec-type="Staging">
        <title>Staging</title>
        <p>Shields et al. introduced the staging of Coats disease in 2000, which is most widely used:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 1 is characterized by retinal telangiectasia</p>
          </list-item>
          <list-item>
            <p>Stage 2 has telangiectasia and intraretinal exudation&#x000a0;
<list list-type="bullet"><list-item><p>Stage 2A: extrafoveal exudation&#x000a0;</p></list-item><list-item><p>Stage 2B: foveal involvement</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Stage 3 denotes&#x000a0;exudative retinal detachment
<list list-type="bullet"><list-item><p>3A is a subtotal detachment
<list list-type="bullet"><list-item><p>3A1: extrafoveal</p></list-item><list-item><p>3A2: foveal involvement</p></list-item></list>
</p></list-item><list-item><p>3B is a total retinal detachment</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Stage 4 has a total retinal detachment plus increased intraocular pressure</p>
          </list-item>
          <list-item>
            <p>Stage 5 is an endstage disease, occasionally with phthisis bulbi<xref ref-type="bibr" rid="article-37391.r5">[5]</xref><xref ref-type="bibr" rid="article-37391.r88">[88]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37391.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Shields et al. reported the visual outcome of 160 patients with Coats disease.<xref ref-type="bibr" rid="article-37391.r89">[89]</xref>&#x000a0;This study found that the advanced stage of the disease was associated with poor visual acuity after treatment. The advanced disease showed less frequent resolution of disease, subretinal fluid, and exudation. The enucleation rate was higher in Stages 4 and 5. Poor visual acuity in advanced stages&#x000a0;was&#x000a0;mainly due to persistent retinal detachment and macular fibrosis. For stages 1&#x000a0;and 2, telangiectatic vessels resolved completely (47%) or partially (53%) over a mean interval of 15 months following treatment.<xref ref-type="bibr" rid="article-37391.r5">[5]</xref>&#x000a0;</p>
        <p>Overall&#x000a0;most cases (76%) stabilized or improved anatomically following treatment. A minority (8%) of patients progressively worsened.<xref ref-type="bibr" rid="article-37391.r5">[5]</xref>&#x000a0;Approximately 20% required enucleation for neovascular glaucoma or painful phthisis bulbi. The risk of recurrence of disease persists even after the resolution of the disease.&#x000a0;Patients should be followed lifelong for recurrence.<xref ref-type="bibr" rid="article-37391.r3">[3]</xref><xref ref-type="bibr" rid="article-37391.r90">[90]</xref><xref ref-type="bibr" rid="article-37391.r91">[91]</xref>&#x000a0;Lack of visual rehabilitation and subretinal fibrotic nodule&#x000a0;indicate poor visual prognosis.<xref ref-type="bibr" rid="article-37391.r92">[92]</xref>&#x000a0;In a series of 67 patients, the identified poor prognostic factors for globe salvage included cataract, diffuse involvement, advanced presentation (stage 3B or worse), anterior hyaloid proliferation, vitreous hemorrhage, preretinal or subretinal fibrosis, and combined or tractional retinal detachment.<xref ref-type="bibr" rid="article-37391.r92">[92]</xref></p>
      </sec>
      <sec id="article-37391.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The clinical course of Coats disease is progressive. Acute exacerbations of the disease infrequently occur, followed by a quiescent state. Spontaneous remissions are rare. In untreated eyes, secondary complications can develop, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Orbital cellulitis (which may simulate retinoblastoma)<xref ref-type="bibr" rid="article-37391.r93">[93]</xref></p>
          </list-item>
          <list-item>
            <p>Neovascularization</p>
          </list-item>
          <list-item>
            <p>Vitreous hemorrhage<xref ref-type="bibr" rid="article-37391.r92">[92]</xref></p>
          </list-item>
          <list-item>
            <p>Cataract</p>
          </list-item>
          <list-item>
            <p>Rubeosis iridis</p>
          </list-item>
          <list-item>
            <p>Neovascular glaucoma</p>
          </list-item>
          <list-item>
            <p>Phthisis bulbi</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37391.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>As Coats disease is idiopathic and sporadic, there are no preventative measures that can be taken by the patients' families. The patients' family members should be appropriately counseled regarding the prognosis of Coats disease and the importance of long-term follow-up.</p>
      </sec>
      <sec id="article-37391.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Any patient presenting with&#x000a0;Coats disease should not only receive treatment by an ophthalmologist as it requires&#x000a0;an interprofessional team evaluation by&#x000a0;pediatricians and oncologists. Interprofessional team communication can lead to better patient management. The patient will most often present to the primary clinician, and these professionals should be aware of the condition as it is treatable. Prompt referral to an ophthalmologist is necessary. These patients can then be followed by their primary clinicians and ensure compliance with treatment. The nursing staff will be the first to the department to come in contact with patients on follow-up and can assess treatment progress as well as evaluate compliance with therapy and report any issues to the primary care clinician. This collaborative, interprofessional approach to care can ensure optimal patient outcomes.</p>
      </sec>
      <sec id="article-37391.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37391&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37391">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/exudative-retinitis-coats-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=37391">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/37391/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=37391">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-37391.s17">
        <fig id="article-37391.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Macular subretinal scar (nodule) and retinal hard exudates in a child with Coats disease Contributed by Koushik Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="coats__disease-001" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37391.s18">
        <fig id="article-37391.image.f2" position="float" orientation="portrait">
          <caption>
            <p>The temporal retina in an eye with Coats disease shows the typical telangiectatic vessels, aneurysms, and hard exudates. Contributed by Koushik Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="coats__disease__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-37391.s19">
        <title>References</title>
        <ref id="article-37391.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kroll</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lou</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>2001</year>
            <season>Fall</season>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>189</fpage>
            <page-range>189-98</page-range>
            <pub-id pub-id-type="pmid">11698747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Honavar</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Demirci</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2001</year>
            <month>May</month>
            <volume>131</volume>
            <issue>5</issue>
            <fpage>561</fpage>
            <page-range>561-71</page-range>
            <pub-id pub-id-type="pmid">11336930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shienbaum</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tasman</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Coats disease: a lifetime disease.</article-title>
            <source>Retina</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>422</fpage>
            <page-range>422-4</page-range>
            <pub-id pub-id-type="pmid">16603961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Honavar</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Coats disease: An overview of classification, management and outcomes.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>67</volume>
            <issue>6</issue>
            <fpage>763</fpage>
            <page-range>763-771</page-range>
            <pub-id pub-id-type="pmid">31124484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Honavar</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Demirci</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cater</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Classification and management of Coats disease: the 2000 Proctor Lecture.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2001</year>
            <month>May</month>
            <volume>131</volume>
            <issue>5</issue>
            <fpage>572</fpage>
            <page-range>572-83</page-range>
            <pub-id pub-id-type="pmid">11336931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sigler</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Randolph</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Calzada</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Haik</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Current management of Coats disease.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <page-range>30-46</page-range>
            <pub-id pub-id-type="pmid">24138893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ye</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cahill</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Badea</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Smallwood</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Peachey</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Nathans</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization.</article-title>
            <source>Cell</source>
            <year>2009</year>
            <month>Oct</month>
            <day>16</day>
            <volume>139</volume>
            <issue>2</issue>
            <fpage>285</fpage>
            <page-range>285-98</page-range>
            <pub-id pub-id-type="pmid">19837032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clevers</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Eyeing up new Wnt pathway players.</article-title>
            <source>Cell</source>
            <year>2009</year>
            <month>Oct</month>
            <day>16</day>
            <volume>139</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-9</page-range>
            <pub-id pub-id-type="pmid">19837026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dickinson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Sale</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Passmore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>FitzGerald</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Wheatley</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Burdon</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tengtrisorn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carden</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Maclean</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2006</year>
            <season>Sep-Oct</season>
            <volume>34</volume>
            <issue>7</issue>
            <fpage>682</fpage>
            <page-range>682-8</page-range>
            <pub-id pub-id-type="pmid">16970763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warden</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Andreoli</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Mukai</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The Wnt signaling pathway in familial exudative vitreoretinopathy and Norrie disease.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2007</year>
            <season>Oct-Dec</season>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>211</fpage>
            <page-range>211-7</page-range>
            <pub-id pub-id-type="pmid">18097984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Oshima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tahira</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.</article-title>
            <source>Hum Mutat</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>104</fpage>
            <page-range>104-12</page-range>
            <pub-id pub-id-type="pmid">15981244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ventruto</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Trese</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Shastry</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Hejtmancik</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5.</article-title>
            <source>Am J Hum Genet</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>75</volume>
            <issue>5</issue>
            <fpage>878</fpage>
            <page-range>878-84</page-range>
            <pub-id pub-id-type="pmid">15346351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>ZY</given-names>
              </name>
              <name>
                <surname>Battinelli</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Fielder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bundey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sims</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Breakefield</surname>
                <given-names>XO</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>IW</given-names>
              </name>
            </person-group>
            <article-title>A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy.</article-title>
            <source>Nat Genet</source>
            <year>1993</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>180</fpage>
            <page-range>180-3</page-range>
            <pub-id pub-id-type="pmid">8252044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cremers</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Maugeri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>den Hollander</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Hoyng</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>The expanding roles of ABCA4 and CRB1 in inherited blindness.</article-title>
            <source>Novartis Found Symp</source>
            <year>2004</year>
            <volume>255</volume>
            <fpage>68</fpage>
            <page-range>68-79; discussion 79-84, 177-8</page-range>
            <pub-id pub-id-type="pmid">14750597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Black</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Perveen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bonshek</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cahill</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Clayton-Smith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis.</article-title>
            <source>Hum Mol Genet</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>11</issue>
            <fpage>2031</fpage>
            <page-range>2031-5</page-range>
            <pub-id pub-id-type="pmid">10484772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shastry</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Trese</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Overproduction and partial purification of the Norrie disease gene product, norrin, from a recombinant baculovirus.</article-title>
            <source>Biochem Biophys Res Commun</source>
            <year>2003</year>
            <month>Dec</month>
            <day>05</day>
            <volume>312</volume>
            <issue>1</issue>
            <fpage>229</fpage>
            <page-range>229-34</page-range>
            <pub-id pub-id-type="pmid">14630047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berger</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>van de Pol</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>B&#x000e4;chner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Oerlemans</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Winkens</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hameister</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wieringa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hendriks</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ropers</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>An animal model for Norrie disease (ND): gene targeting of the mouse ND gene.</article-title>
            <source>Hum Mol Genet</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-9</page-range>
            <pub-id pub-id-type="pmid">8789439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luhmann</surname>
                <given-names>UF</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Acar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lammel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grimm</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seeliger</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Hammes</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>46</volume>
            <issue>9</issue>
            <fpage>3372</fpage>
            <page-range>3372-82</page-range>
            <pub-id pub-id-type="pmid">16123442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohlmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scholz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goldwich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Hudl</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ohlmann</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Zrenner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cvekl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seeliger</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Tamm</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice.</article-title>
            <source>J Neurosci</source>
            <year>2005</year>
            <month>Feb</month>
            <day>16</day>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>1701</fpage>
            <page-range>1701-10</page-range>
            <pub-id pub-id-type="pmid">15716406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sohn</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Michaelides</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Smyth</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brady</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Hungerford</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Novel mutation in PANK2 associated with retinal telangiectasis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>149</fpage>
            <page-range>149-50</page-range>
            <pub-id pub-id-type="pmid">20974629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Foot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mulvihill</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A population-based study of Coats disease in the United Kingdom I: epidemiology and clinical features at diagnosis.</article-title>
            <source>Eye (Lond)</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>12</issue>
            <fpage>1797</fpage>
            <page-range>1797-801</page-range>
            <pub-id pub-id-type="pmid">20865031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campbell</surname>
                <given-names>FP</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease and congenital vascular retinopathy.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1976</year>
            <volume>74</volume>
            <fpage>365</fpage>
            <page-range>365-424</page-range>
            <pub-id pub-id-type="pmid">325857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rishi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rishi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Appukuttan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Uparkar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gopal</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease of adult-onset in 48 eyes.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>64</volume>
            <issue>7</issue>
            <fpage>518</fpage>
            <page-range>518-23</page-range>
            <pub-id pub-id-type="pmid">27609165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egbert</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Flat preparations of the retinal vessels in Coats' disease.</article-title>
            <source>J Pediatr Ophthalmol</source>
            <year>1976</year>
            <season>Nov-Dec</season>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>336</fpage>
            <page-range>336-9</page-range>
            <pub-id pub-id-type="pmid">798026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernandes</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Odashiro</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Maloney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zajdenweber</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Burnier</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Clinical-histopathological correlation in a case of Coats' disease.</article-title>
            <source>Diagn Pathol</source>
            <year>2006</year>
            <month>Aug</month>
            <day>30</day>
            <volume>1</volume>
            <fpage>24</fpage>
            <pub-id pub-id-type="pmid">16942617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ashton</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Electron microscopical study of Coat's disease.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1971</year>
            <month>May</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>289</fpage>
            <page-range>289-301</page-range>
            <pub-id pub-id-type="pmid">4102954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DUKE</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>WOODS</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>COATS'S DISEASE. II. STUDIES ON THE IDENTITY OF THE LIPIDS CONCERNED, AND THE PROBABLE ROLE OF MUCOPOLYSACCHARIDES IN ITS PATHOGENESIS.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1963</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>7</issue>
            <fpage>413</fpage>
            <page-range>413-34</page-range>
            <pub-id pub-id-type="pmid">14189711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>Merritt</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease: a study of 62 histologically confirmed cases.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>1984</year>
            <season>Sep-Oct</season>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>163</fpage>
            <page-range>163-8</page-range>
            <pub-id pub-id-type="pmid">6502405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farkas</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Potts</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Boone</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Some pathologic and biochemical aspects of Coats' disease.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1973</year>
            <month>Feb</month>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>289</fpage>
            <page-range>289-301</page-range>
            <pub-id pub-id-type="pmid">4348894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takei</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Origin of ghost cell in Coats' disease.</article-title>
            <source>Invest Ophthalmol</source>
            <year>1976</year>
            <month>Aug</month>
            <volume>15</volume>
            <issue>8</issue>
            <fpage>677</fpage>
            <page-range>677-81</page-range>
            <pub-id pub-id-type="pmid">955836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fukuhara</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Noda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kanda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ishida</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Expression of vascular endothelial growth factor in eyes with Coats' disease.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2013</year>
            <month>Jan</month>
            <day>07</day>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-62</page-range>
            <pub-id pub-id-type="pmid">23221067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Beri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>D'souza</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cholesterolosis Bulbi of the Anterior Chamber in Coats Disease.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>2009</year>
            <month>Jun</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">19645389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Fammartino</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>De Potter</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease as a cause of anterior chamber cholesterolosis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1995</year>
            <month>Aug</month>
            <volume>113</volume>
            <issue>8</issue>
            <fpage>975</fpage>
            <page-range>975-7</page-range>
            <pub-id pub-id-type="pmid">7639669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reichstein</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Recchia</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Coats disease and exudative retinopathy.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>2011</year>
            <season>Winter</season>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-112</page-range>
            <pub-id pub-id-type="pmid">21139479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedenwald</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Friedenwald</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Terminal Stage in a Case of Retinitis with Massive Exudation.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1929</year>
            <volume>27</volume>
            <fpage>188</fpage>
            <page-range>188-94</page-range>
            <pub-id pub-id-type="pmid">16692828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naumann</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Portwich</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[Etiology and final clinical cause for 1000 enucleations. (A clinico-pathologic study) (author's transl)].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>1976</year>
            <month>May</month>
            <volume>168</volume>
            <issue>05</issue>
            <fpage>622</fpage>
            <page-range>622-30</page-range>
            <pub-id pub-id-type="pmid">957559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Temkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pushker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
            </person-group>
            <article-title>Phthisis Bulbi-a Clinicopathological Perspective.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2018</year>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>788</fpage>
            <page-range>788-803</page-range>
            <pub-id pub-id-type="pmid">29902388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r38">
          <label>38</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Fluorescein Angiography</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunha-Vaz</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>The blood-retinal barriers.</article-title>
            <source>Doc Ophthalmol</source>
            <year>1976</year>
            <month>Oct</month>
            <day>15</day>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>287</fpage>
            <page-range>287-327</page-range>
            <pub-id pub-id-type="pmid">1009819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ridley</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Tasman</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease. Evaluation of management.</article-title>
            <source>Ophthalmology</source>
            <year>1982</year>
            <month>Dec</month>
            <volume>89</volume>
            <issue>12</issue>
            <fpage>1381</fpage>
            <page-range>1381-7</page-range>
            <pub-id pub-id-type="pmid">6891766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarkkanen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laatikainen</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Coat's disease: clinical, angiographic, histopathological findings and clinical management.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1983</year>
            <month>Nov</month>
            <volume>67</volume>
            <issue>11</issue>
            <fpage>766</fpage>
            <page-range>766-76</page-range>
            <pub-id pub-id-type="pmid">6685529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Wessel</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>RV</given-names>
              </name>
            </person-group>
            <article-title>Ultra-widefield imaging for the management of pediatric retinal diseases.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>2013</year>
            <season>Sep-Oct</season>
            <volume>50</volume>
            <issue>5</issue>
            <fpage>282</fpage>
            <page-range>282-8</page-range>
            <pub-id pub-id-type="pmid">23739460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Udyaver</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dalvin</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Atalay</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>L Khoo</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Mazloumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>67</volume>
            <issue>6</issue>
            <fpage>772</fpage>
            <page-range>772-783</page-range>
            <pub-id pub-id-type="pmid">31124485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ong</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Mruthyunjaya</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stinnett</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vajzovic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Toth</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Macular Features on Spectral-Domain Optical Coherence Tomography Imaging Associated With Visual Acuity in Coats' Disease.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2018</year>
            <month>Jun</month>
            <day>01</day>
            <volume>59</volume>
            <issue>7</issue>
            <fpage>3161</fpage>
            <page-range>3161-3174</page-range>
            <pub-id pub-id-type="pmid">30025132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashkenazy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Acon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kalavar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berrocal</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography angiography and multimodal imaging in the management of coats' disease.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>23</volume>
            <fpage>101177</fpage>
            <pub-id pub-id-type="pmid">34381924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hautz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Go&#x00142;&#x00119;biewska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kocy&#x00142;a-Karczmarewicz</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Optical Coherence Tomography and Optical Coherence Tomography Angiography in Monitoring Coats' Disease.</article-title>
            <source>J Ophthalmol</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>7849243</fpage>
            <pub-id pub-id-type="pmid">28377823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muakkassa</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>de Carlo</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Choudhry</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Baumal</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Optical Coherence Tomography Angiography Findings in Coats' Disease.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2016</year>
            <month>Jul</month>
            <day>01</day>
            <volume>47</volume>
            <issue>7</issue>
            <fpage>632</fpage>
            <page-range>632-5</page-range>
            <pub-id pub-id-type="pmid">27434894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisenberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kwock</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mukherji</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Proton MR spectroscopy in Coats disease.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>727</fpage>
            <page-range>727-9</page-range>
            <pub-id pub-id-type="pmid">9127038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Potter</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Flanders</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>The role of magnetic resonance imaging in children with intraocular tumors and simulating lesions.</article-title>
            <source>Ophthalmology</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>103</volume>
            <issue>11</issue>
            <fpage>1774</fpage>
            <page-range>1774-83</page-range>
            <pub-id pub-id-type="pmid">8942869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Senft</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Hidayat</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Cavender</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Atypical presentation of Coats disease.</article-title>
            <source>Retina</source>
            <year>1994</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-8</page-range>
            <pub-id pub-id-type="pmid">8016459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schefler</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Berrocal</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Advanced Coats' disease. Management with repetitive aggressive laser ablation therapy.</article-title>
            <source>Retina</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3 Suppl</issue>
            <fpage>S38</fpage>
            <page-range>S38-41</page-range>
            <pub-id pub-id-type="pmid">18317343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spitznas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Joussen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wessing</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Coats' disease with photocoagulation.</article-title>
            <source>Albrecht Von Graefes Arch Klin Exp Ophthalmol</source>
            <year>1976</year>
            <month>Apr</month>
            <day>01</day>
            <volume>199</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-7</page-range>
            <pub-id pub-id-type="pmid">1083682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shapiro</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Karth</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kiernan</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Effects of green diode laser in the treatment of pediatric Coats disease.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>151</volume>
            <issue>4</issue>
            <fpage>725</fpage>
            <page-range>725-731.e2</page-range>
            <pub-id pub-id-type="pmid">21257148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Review: coats disease: the 2001 LuEsther T. Mertz lecture.</article-title>
            <source>Retina</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-91</page-range>
            <pub-id pub-id-type="pmid">11884883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease, diagnosis and treatment.</article-title>
            <source>Can J Ophthalmol</source>
            <year>1970</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>311</fpage>
            <page-range>311-20</page-range>
            <pub-id pub-id-type="pmid">5481542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Othman</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Moussa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bouhaimed</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2010</year>
            <month>May</month>
            <volume>94</volume>
            <issue>5</issue>
            <fpage>606</fpage>
            <page-range>606-10</page-range>
            <pub-id pub-id-type="pmid">19955197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jarin</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Teoh</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide.</article-title>
            <source>Eye (Lond)</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>163</fpage>
            <page-range>163-5</page-range>
            <pub-id pub-id-type="pmid">15723038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>3</issue>
            <fpage>236</fpage>
            <page-range>236-41</page-range>
            <pub-id pub-id-type="pmid">26040225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghazi</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Al Shamsi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abboud</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal triamcinolone in Coats' disease.</article-title>
            <source>Ophthalmology</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>119</volume>
            <issue>3</issue>
            <fpage>648</fpage>
            <page-range>648-9</page-range>
            <pub-id pub-id-type="pmid">22385486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Entezari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ramezani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Safavizadeh</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bassirnia</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Resolution of macular edema in Coats' disease with intravitreal bevacizumab.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2010</year>
            <season>Jan-Feb</season>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-2</page-range>
            <pub-id pub-id-type="pmid">20029156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alvarez-Rivera</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Abraham-Mar&#x000ed;n</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Flores-Orta</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Mayorqu&#x000ed;n-Ruiz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cort&#x000e9;s-Luna</surname>
                <given-names>CF</given-names>
              </name>
            </person-group>
            <article-title>[Coat's disease treated with bevacizumab (Avastin)].</article-title>
            <source>Arch Soc Esp Oftalmol</source>
            <year>2008</year>
            <month>May</month>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>329</fpage>
            <page-range>329-31</page-range>
            <pub-id pub-id-type="pmid">18464184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SN</given-names>
              </name>
            </person-group>
            <article-title>The effect of intravitreal bevacizumab in the treatment of Coats disease in children.</article-title>
            <source>Retina</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>617</fpage>
            <page-range>617-22</page-range>
            <pub-id pub-id-type="pmid">19996822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaillard</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mataftsi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Balmer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Houghton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Munier</surname>
                <given-names>FL</given-names>
              </name>
            </person-group>
            <article-title>ranibizumab in the management of advanced Coats disease Stages 3B and 4: long-term outcomes.</article-title>
            <source>Retina</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>11</issue>
            <fpage>2275</fpage>
            <page-range>2275-81</page-range>
            <pub-id pub-id-type="pmid">25075562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zheng</surname>
                <given-names>XX</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>YR</given-names>
              </name>
            </person-group>
            <article-title>The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>252</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">23873253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2017</year>
            <month>May</month>
            <day>22</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>76</fpage>
            <pub-id pub-id-type="pmid">28532448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r66">
          <label>66</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kanukollu</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Leukocoria</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32809629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r67">
          <label>67</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Ocular Toxocariasis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r68">
          <label>68</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Simakurthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Endophthalmitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32644505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Janowicz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cholesterol Crystals Secondary to Coats-Like Response With Retinitis Pigmentosa.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2017</year>
            <month>Oct</month>
            <day>12</day>
            <volume>135</volume>
            <issue>10</issue>
            <fpage>e173132</fpage>
            <pub-id pub-id-type="pmid">29049676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhatia</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Coats like response in healed choroiditis.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>1527</fpage>
            <page-range>1527-1529</page-range>
            <pub-id pub-id-type="pmid">33797302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nair</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kummamuri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sudharshan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khetan</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Coats-like response in tubercular subretinal abscess masquerading as melanoma as the initial manifestation of miliary tuberculosis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>68</volume>
            <issue>9</issue>
            <fpage>2040</fpage>
            <page-range>2040-2043</page-range>
            <pub-id pub-id-type="pmid">32823473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaudhary</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Varshney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Videkar</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Secondary Coats' response to retinal vasculitis managed with bevacizumab.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>66</volume>
            <issue>9</issue>
            <fpage>1355</fpage>
            <page-range>1355-1357</page-range>
            <pub-id pub-id-type="pmid">30127171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suh</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Pulido</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Coats'-like response in pars planitis.</article-title>
            <source>Retina</source>
            <year>1999</year>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>79</fpage>
            <page-range>79-80</page-range>
            <pub-id pub-id-type="pmid">10048380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r74">
          <label>74</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Chauhan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Pars Planitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">28613790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>LP</given-names>
              </name>
            </person-group>
            <article-title>Coats'-like response in a patient with pars planitis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>80</volume>
            <issue>7</issue>
            <fpage>675</fpage>
            <page-range>675-6</page-range>
            <pub-id pub-id-type="pmid">8795387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tewari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ultra wide field imaging of coats like response in Leber's congenital amaurosis.</article-title>
            <source>Saudi J Ophthalmol</source>
            <year>2017</year>
            <season>Apr-Jun</season>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-123</page-range>
            <pub-id pub-id-type="pmid">28559726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pilania</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Anjani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Choudhary</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Retinal Vasculitis With Coats-Like Response in a Young Girl With Parry-Romberg Syndrome.</article-title>
            <source>J Clin Rheumatol</source>
            <year>2021</year>
            <month>Dec</month>
            <day>01</day>
            <volume>27</volume>
            <issue>8S</issue>
            <fpage>S543</fpage>
            <page-range>S543-S545</page-range>
            <pub-id pub-id-type="pmid">31124919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fan</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>McAllister</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Prakhunhungsit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Negron</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Cap&#x000f3;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Berrocal</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>X-Linked Retinoschisis and a Coats-Like Response in the Setting of Retinopathy of Prematurity.</article-title>
            <source>J Vitreoretin Dis</source>
            <year>2020</year>
            <month>Nov</month>
            <day>01</day>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>525</fpage>
            <page-range>525-529</page-range>
            <pub-id pub-id-type="pmid">34622118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gelisken</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sherif Adel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Inhoffen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bartz-Schmidt</surname>
                <given-names>KU</given-names>
              </name>
            </person-group>
            <article-title>Coats'-like response in blood-filled senile retinoschisis.</article-title>
            <source>Ophthalmologica</source>
            <year>2002</year>
            <season>Sep-Oct</season>
            <volume>216</volume>
            <issue>5</issue>
            <fpage>377</fpage>
            <page-range>377-9</page-range>
            <pub-id pub-id-type="pmid">12424408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Behboudi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zayeni</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Haji-Abbasi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moravvej</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Azaripour</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alizadeh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Soltani-Moghadam</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Coats'-like Response Associated with Linear Scleroderma.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2022</year>
            <season>Jan-Mar</season>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>135</fpage>
            <page-range>135-139</page-range>
            <pub-id pub-id-type="pmid">35194504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Bernardino</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Coats-like response in linear en coup de sabre scleroderma.</article-title>
            <source>Retin Cases Brief Rep</source>
            <year>2011</year>
            <season>Fall</season>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>275</fpage>
            <page-range>275-8</page-range>
            <pub-id pub-id-type="pmid">25390412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Blodi</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.</article-title>
            <source>Ophthalmology</source>
            <year>1993</year>
            <month>Oct</month>
            <volume>100</volume>
            <issue>10</issue>
            <fpage>1536</fpage>
            <page-range>1536-46</page-range>
            <pub-id pub-id-type="pmid">8414413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Bardal</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Eandi</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Blodi</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic macular telangiectasia.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>124</volume>
            <issue>4</issue>
            <fpage>450</fpage>
            <page-range>450-60</page-range>
            <pub-id pub-id-type="pmid">16606869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Papasavvas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fleischhauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Peripheral Inflammatory Yellow Exudative Retinal Coats-Like Vitreoretinopathy Misdiagnosed as Acute Retinal Necrosis in a Retinitis Pigmentosa Patient after Cataract Surgery.</article-title>
            <source>Case Rep Ophthalmol</source>
            <year>2021</year>
            <season>May-Aug</season>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>562</fpage>
            <page-range>562-568</page-range>
            <pub-id pub-id-type="pmid">34248592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r85">
          <label>85</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bergstrom</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Acute Retinal Necrosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">29262034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fitzsimons</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Gurwin</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications.</article-title>
            <source>Brain</source>
            <year>1987</year>
            <month>Jun</month>
            <volume>110 ( Pt 3)</volume>
            <fpage>631</fpage>
            <page-range>631-48</page-range>
            <pub-id pub-id-type="pmid">3580827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vance</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>Subclinical facioscapulohumeral muscular dystrophy masquerading as bilateral Coats disease in a woman.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>129</volume>
            <issue>6</issue>
            <fpage>807</fpage>
            <page-range>807-9</page-range>
            <pub-id pub-id-type="pmid">21670353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cahill</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Keefe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Acheson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mulvihill</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mooney</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation.</article-title>
            <source>Acta Ophthalmol Scand</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>79</volume>
            <issue>6</issue>
            <fpage>596</fpage>
            <page-range>596-602</page-range>
            <pub-id pub-id-type="pmid">11782226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Udyaver</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dalvin</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Atalay</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Khoo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mazloumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Visual acuity outcomes in Coats disease by classification stage in 160 patients.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>104</volume>
            <issue>3</issue>
            <fpage>422</fpage>
            <page-range>422-431</page-range>
            <pub-id pub-id-type="pmid">31177186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egerer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tasman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tomer</surname>
                <given-names>TT</given-names>
              </name>
            </person-group>
            <article-title>Coats disease.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1974</year>
            <month>Aug</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-12</page-range>
            <pub-id pub-id-type="pmid">4847500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tasman</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease.</article-title>
            <source>Am Fam Physician</source>
            <year>1977</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>107</fpage>
            <pub-id pub-id-type="pmid">848416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shanmugam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ramanjulu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Coats' disease - Prognostic factors for globe and vision salvage in children, a long-term experience.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>70</volume>
            <issue>2</issue>
            <fpage>483</fpage>
            <page-range>483-489</page-range>
            <pub-id pub-id-type="pmid">35086222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37391.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Judisch</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Apple</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Orbital cellulitis in an infant secondary to Coats' disease.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1980</year>
            <month>Nov</month>
            <volume>98</volume>
            <issue>11</issue>
            <fpage>2004</fpage>
            <page-range>2004-6</page-range>
            <pub-id pub-id-type="pmid">7436836</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
